Search…
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Search...
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Home
>
Latest
Lates News
09/04/2026
Kuwait's Consumer Price Index rose by 0.14% month-on-month in February.
Latest
4 m ago
GF Fund Crude Oil LOF: Trading will be suspended from market opening on April 10, 2026 until 10:30 on the same day, and will resume from 10:30 on April 10, 2026; redemption services for this fund will continue to be processed during the suspension period.
4 m ago
Cheng Lian Branch Cui Dongshu: It is expected that the car market will see positive growth in the second half of the year.
4 m ago
Guotou Silver LOF: It will be suspended from trading starting on April 10, 2026, until 10:30 on the same day. Trading will resume at 10:30 on April 10, 2026. Redemption services for this fund will be conducted as usual during the suspension period.
4 m ago
Crude Oil LOF E Fund: It will be suspended from the market from the market opening on April 10, 2026 until 10:30 on the same day, and resume trading at 10:30 on April 10, 2026; during the suspension period, the redemption business of this fund will be conducted as usual.
5 m ago
Kangchen Pharmaceuticals: KC1036 second-line therapy for late-stage esophageal squamous cell carcinoma pivotal Phase III clinical study approved by CDE.
See all latest